Decreased cerebral blood flow and prognosis of Alzheimer's disease: A multicenter HMPAO-SPECT study

Annals of Nuclear Medicine

Volumn 21, Issue 1, 2007, Pages 15-23

  Nishimura, Tsunehiko ^a   Hashikawa, Kazuo ^b   Fukuyama, Hidenao ^b   Kubota, Takao ^a   Kitamura, Shin ^c   Matsuda, Hiroshi ^d   Hanyu, Haruo ^e   Nabatame, Hidehiko ^f   Oku, Naohiko ^g   Tanabe, Hirotaka ^h   Kuwabara, Yasuo ⁱ   Jinnouchi, Seishi ^j   Kubo, Atsushi ^k  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^e TOKYO MEDICAL UNIVERSITY   (Japan)

^f Shiga Medical Center for Adults   (Japan)

^g OSAKA UNIVERSITY   (Japan)

^h EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

^j UNIVERSITY OF MIYAZAKI   (Japan)

^k KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

3D SSP; Alzheimer's disease

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN REGION; CINGULATE GYRUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COURSE EVALUATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION IMPAIRMENT SCALE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PARIETAL LOBE; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; RAVEN COLORED PROGRESSION MATRIX; SAMPLE SIZE; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

EID: 33847156890     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033995     Document Type: Article

References (21)

1. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36: 1238-1248.
2. Kubota T, Ushijima Y, Yamada K, Okuyama C, Kizu O, Nishimura T. Diagnosis of Alzheimer's disease using brain perfusion SPECT and MR imaging: which modality achieves better diagnostic accuracy? Eur J Nucl Med Mol Imaging 2005; 32 (4): 414-421.
3. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632-637.
4. Barber R, Snowden JS, Craufurd D. Front temporal dementia and Alzheimer's disease: retrospective differentiation using information from informants. J Neurol Neurosurg Psychiatry 1995; 59: 61-70.
5. Homma A, Niina R, Ishii T, Hasegawa K. Development of a new rating scale for dementia in the elderly: Mental Function Impairment Scale (MENFIS). Jpn J Geriatr Psychiatry 1991; 2: 1217-1222.
6. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12 (3): 189-198.
7. Aftanas MS, Royce JR. A factor analysis of brain damage tests administered to normal subjects with factor score comparisons across ages. Multiv Behave Res 1964; 4: 459-481.
8. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulated cortex in very early Alzheimer's disease. Ann Neurol 1997; 42 (1): 85-94.
9. Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994; 35: 1528-1537.
10. Minoshima S, Koeppe RA, Frey KA, Ishihara M, Kuhl DE. Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images. J Nucl Med 1994; 35: 949-954.
11. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York; Thieme.
12. Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frolich L, et al. Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET. Neuroimage 2002; 17: 302-316.
13. Haxby JV, Grady CL, Koss E, Horwitz B, Schapiro M, Friedland RP, et al. Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology 1988; 38: 1853-1863.
14. Nebu A, Ikeda M, Fukuhara R, Shigenobu K, Maki N, Hokoishi K, et al. Relationship between blood flow kinetics and severity of Alzheimer's disease: Assessment of severity using a questionnaire type examination, Alzheimer's disease assessment scale, cognitive sub-scale (ADAScog). Dement Geriatr Cogn Disord 2001; 12: 318-325.
15. Kaneko K, Kuwabara Y, Sasaki M, Ogomori K, Ichimiya A, Koga H, et al. Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT. Clin Nucl Med 2004; 29 (6): 362-366.
16. Brown DR, Hunter R, Wyper DJ, Patterson J, Kelly RC, Montaldi D, et al. Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: A SPECT blood flow study. J Psychiatr Res 1996; 30: 109-126.
17. Nagahama Y, Nabatame H, Okina T, Yamauchi H, Narita M, Fujimoto N, et al. Cerebral correlates of the progression rate of the cognitive decline in probable Alzheimer's disease. Eur Nurol 2003; 50 (1): 1-9.
18. Hogh P, Knudsen GM, Kjaer KH, Jorgensen OS, Paulson OB, Waldemar GJ. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow. Neurol 2001; 14 (1): 42-51.
19. Sakamoto S, Matsuda H, Asada T, Ohnishi T, Nakano S, Kanetaka H, et al. Apolipoprotein E genotype and early Alzheimer's disease: a longitudinal SPECT study. J Neuroimaging 2003; 13 (2): 113-123.
20. Corder EH, Jelic V, Basun H, Lannfelt L, Valind S, Winblad B, et al. No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Arch Neurol 1997; 54: 273-277.
21. Hirono N, Mori E, Yasuda M, Ishii K, Ikejiri Y, Imamura T, et al. Lack of association of apolipoprotein E ε4 allele dose with cerebral glucose metabolism in Alzheimer disease. Alzheimer Dis Assoc Dis 1998; 12: 362-367.